成大生物
(688739)
| 流通市值：82.90亿 | | | 总市值：83.87亿 |
| 流通股本：4.12亿 | | | 总股本：4.16亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 677,265,772.37 | 273,347,755.58 | 1,390,287,449 | 1,095,886,627.32 |
| 营业总成本 | 591,653,690.31 | 269,281,252.62 | 1,175,494,522.57 | 863,198,199.48 |
| 其他经营收益 | | | | |
| 营业利润 | 55,168,854.51 | 1,314,214.45 | 171,039,531.79 | 212,156,721.04 |
| 利润总额 | 54,950,493.85 | 1,232,164.27 | 169,604,544.3 | 211,147,469.69 |
| 净利润 | 33,280,559.87 | -1,907,712.15 | 131,790,329.4 | 164,812,017.55 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 33,280,559.87 | -1,907,712.15 | 131,790,329.4 | 164,812,017.55 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 6,781,720,944.08 | 6,721,488,005.02 | 6,787,007,652.65 | 6,770,220,658.4 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,913,832,758.56 | 2,954,062,988.89 | 2,959,200,258.88 | 3,032,533,620.11 |
| 资产总计 | 9,695,553,702.64 | 9,675,550,993.91 | 9,746,207,911.53 | 9,802,754,278.51 |
| 流动负债: | | | | |
| 流动负债合计 | 276,040,472.98 | 236,494,626.79 | 300,634,287.45 | 327,292,830.49 |
| 非流动负债: | | | | |
| 非流动负债合计 | 80,398,655.59 | 86,805,282.67 | 91,414,827.48 | 88,280,963.27 |
| 负债合计 | 356,439,128.57 | 323,299,909.46 | 392,049,114.93 | 415,573,793.76 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 9,337,114,586.09 | 9,352,251,084.45 | 9,354,158,796.6 | 9,387,180,484.75 |
| 股东权益合计 | 9,339,114,574.07 | 9,352,251,084.45 | 9,354,158,796.6 | 9,387,180,484.75 |
| 负债和股东权益合计 | 9,695,553,702.64 | 9,675,550,993.91 | 9,746,207,911.53 | 9,802,754,278.51 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 634,745,713.98 | 302,211,207.62 | 1,496,967,738.95 | 1,044,919,438.25 |
| 经营活动现金流出小计 | 563,983,967.81 | 282,563,975.02 | 1,156,102,806.45 | 873,901,457.27 |
| 经营活动产生的现金流量净额 | 70,761,746.17 | 19,647,232.6 | 340,864,932.5 | 171,017,980.98 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 4,296,848,837.31 | 1,388,524,864.21 | 4,774,561,499.23 | 3,526,438,967.31 |
| 投资活动现金流出小计 | 5,086,618,234.32 | 2,079,612,946.1 | 4,901,440,079.87 | 3,841,337,519.09 |
| 投资活动产生的现金流量净额 | -789,769,397.01 | -691,088,081.89 | -126,878,580.64 | -314,898,551.78 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 2,000,000 | - | - | - |
| 筹资活动现金流出小计 | 52,881,885.4 | 28,000 | 346,533,326.19 | 343,488,571.57 |
| 筹资活动产生的现金流量净额 | -50,881,885.4 | -28,000 | -346,533,326.19 | -343,488,571.57 |
| 汇率变动对现金及现金等价物的影响 | -1,429,594.44 | -925,002.16 | 685,773.15 | 970,746.96 |
| 现金及现金等价物净增加额 | -771,319,130.68 | -672,393,851.45 | -131,861,201.18 | -486,398,395.41 |
| 期末现金及现金等价物余额 | 3,594,871,114.93 | 3,693,796,394.16 | 4,366,190,245.61 | 4,011,653,051.38 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -771,319,130.68 | - | -131,861,201.18 | - |